Beijing Hanmi Pharm strengthens presence in China

Published: 2003-10-31 06:39:00

Updated: 2003-10-31 06:39:00

The business presence of Beijing Hanmi Pharm in China, of which 70 percent stake is owned by Hanmi Pharm, has expanded rapidly in the past years, partly helped by its direct marketing and localization strategies including brisk sales records in the niche market, said a local analyst in a statemen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK